Acute lymphoblastic leukemia: Clinical practice guidelines in oncology

Joseph C. Alvarnas*, Patrick A. Brown, Patricia Aoun, Karen Kuhn Ballen, Naresh Bellam, William Blum, Michael W. Boyer, Hetty E. Carraway, Peter F. Coccia, Steven E. Coutre, Jennifer Cultrera, Lloyd E. Damon, Daniel J. DeAngelo, Dan Douer, Haydar Frangoul, Olga Frankfurt, Salil Goorha, Michael M. Millenson, Susan O'Brien, Stephen H. PetersdorfArati V. Rao, Stephanie Terezakis, Geoffrey Uy, Meir Wetzler, Andrew D. Zelenetz, Maoko Naganuma, Kristina M. Gregory

*Corresponding author for this work

Research output: Contribution to journalReview article

41 Scopus citations

Abstract

The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

Original languageEnglish (US)
Pages (from-to)858-914
Number of pages57
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number7
DOIs
StatePublished - Jul 1 2012

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Acute lymphoblastic leukemia: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this